Michael Chi - 23 Jul 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Commercial Officer
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
23 Jul 2024
Net transactions value
-$359,054
Form type
4
Filing time
25 Jul 2024, 16:41:03 UTC
Previous filing
16 Jul 2024
Next filing
02 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $104,250 +7,500 +4% $13.90 192,826 23 Jul 2024 Direct F1
transaction HIMS Class A Common Stock Sale $165,000 -7,500 -3.9% $22.00 185,326 23 Jul 2024 Direct F1
transaction HIMS Class A Common Stock Options Exercise $86,688 +17,303 +9.3% $5.01 202,629 24 Jul 2024 Direct F1
transaction HIMS Class A Common Stock Sale $384,992 -17,303 -8.5% $22.25 185,326 24 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -7,500 -7.8% $0.000000 89,082 23 Jul 2024 Class A Common Stock 7,500 $13.90 Direct F1, F2
transaction HIMS Stock Option (right to buy) Options Exercise $0 -17,303 -5% $0.000000 328,766 24 Jul 2024 Class A Common Stock 17,303 $5.01 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
F2 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.
F3 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.